Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 59.20
-1.50 (-2.47%)
Jul 6, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.02 billion as of July 6, 2026. Its market cap has decreased by -46.19% in one year.
Market Cap
1.02B
Enterprise Value
992.77M
Revenue
257.50M
Ranking
n/a
PE Ratio
67.84
Stock Price
59.20
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.02B, a decrease of -24.61%. That is a compound annual growth rate of -6.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 1.02B | -46.42% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C-Rad AB | 1.23B |
| BICO Group AB | 1.16B |
| Paxman AB | 1.13B |
| Sedana Medical AB | 864.23M |
| Senzime AB | 676.02M |
| Bactiguard Holding AB | 560.70M |
| OssDsign AB | 454.67M |
| Ortoma AB | 442.13M |